172 related articles for article (PubMed ID: 24692842)
1. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Wang S; Fang W
Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M
Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer.
Tao F; Ye MF; Sun AJ; Lv JQ; Xu GG; Jing YM; Wang W
World J Gastroenterol; 2014 Jul; 20(28):9564-9. PubMed ID: 25071353
[TBL] [Abstract][Full Text] [Related]
6. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.
Zhang J; Chen N; Qi J; Zhou B; Qiu X
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1441-9. PubMed ID: 24770635
[TBL] [Abstract][Full Text] [Related]
7. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
8. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
[TBL] [Abstract][Full Text] [Related]
9. The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations.
Olcha P; Cybulski M; Skomra D; Obrzut B; Ignatov A; Jóźwik M; Schneider-Stock R; Semczuk A
Int J Gynecol Cancer; 2010 Aug; 20(6):993-9. PubMed ID: 20683407
[TBL] [Abstract][Full Text] [Related]
10. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
12. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival.
Geisler JP; Geisler HE; Manahan KJ; Miller GA; Wiemann MC; Zhou Z; Crabtree W
Int J Gynecol Cancer; 2004; 14(1):133-7. PubMed ID: 14764041
[TBL] [Abstract][Full Text] [Related]
16. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
Li D; Han Z; Liu J; Zhang X; Ren J; Yan L; Liu H; Xu Z
Med Oncol; 2013 Dec; 30(4):702. PubMed ID: 23999841
[TBL] [Abstract][Full Text] [Related]
18. Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study.
Gabriel B; Hasenburg A; Waizenegger M; Orlowska-Volk M; Stickeler E; zur Hausen A
Int J Gynecol Cancer; 2009 Oct; 19(7):1221-5. PubMed ID: 19823058
[TBL] [Abstract][Full Text] [Related]
19. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
[TBL] [Abstract][Full Text] [Related]
20. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
Uyama H; Tomita Y; Nakamura H; Nakamori S; Zhang B; Hoshida Y; Enomoto H; Okuda Y; Sakon M; Aozasa K; Kawase I; Hayashi N; Monden M
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6043-8. PubMed ID: 17062679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
